79225044

Information

• Trademark
• 79225044

• Source

• Serial Number

  79225044

• Registration Number

  5671918

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 45 - Legal services

• Filing Date

  October 11, 2017
  6 years ago

• Registration Date

  February 12, 2019
  5 years ago

• Transaction Date

  February 12, 2024
  4 months ago

• Status Date

  February 12, 2019
  5 years ago

• Published for Opposition Date

  November 27, 2018
  5 years ago

• Location Date

  February 12, 2019
  5 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  VAGHANI, MAYUR C

• Attorney Docket Number

  155191.00018

  Attorney Name

  Paul F Kilmer

  Law Office Assigned Location Code

  N60

• Owners

  • Ascendis Pharma A/S

Case File Statements

• DM0000: The mark consists of a polygon that is divided by a white curved band with the top section being in turquoise and the bottom section in blue.
• GS0051: Pharmaceutical and veterinary preparations for the treatment of physical and mental illness, namely, pharmaceutical preparations for use in enzyme replacement therapy; pharmaceutical and veterinary preparations, namely, vaccines for the treatment of physical and mental illness; pharmaceutical and veterinary preparations for the treatment of physical and mental illness, namely, pharmaceutical preparations for the prevention and treatment of disorders of the endocrine system, growth hormone deficiencies, hypoparathyroidism, achondroplasia, diabetes, fibroblast growth factor receptor(FGFR)-related skeletal disorders, oncological disorders, ophthalmologic disorders, infectious diseases, enzyme replacement therapy, anti-inflammatory diseases, pain, respiratory system disorders, autoimmune disorders, vaccines, non-alcoholic steatohepatitis, brain diseases, bone diseases, CNS diseases, myopathies, obesity, wounds healing, the hormonal system disorders, namely, growth hormone deficiencies, diabetes and angiogenesis, the ophthalmological system disorders, namely, angiogenesis, the angiogenic system disorders, the central nervous system disorders, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, the immune system disorders, namely, immunologic diseases, namely, autoimmune diseases and immunologic deficiency syndromes, the cardio-vascular system diseases, the metabolic system disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, the respiratory system, the musculo-skeletal system disorders, namely, growth hormone deficiencies, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, the genitourinary system disorders, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of inflammatory disorders, namely, anti-inflammatories; pharmaceutical preparations for use in dermatology, namely, dermatitis, eczema, psoriasis; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in in ophthalmology; pharmaceutical preparations for use in the treatment of gastroenterological disorders; sanitary preparations for medical purposes, namely, sanitizing wipes, disinfectants for medical instruments, adhesive tapes for medical purposes, dietetic foods, namely, dietetic sugar substitutes adapted for medical use, all-purpose disinfectants for sanitary purposes; fungicides, herbicides
• CC0000: The color(s) turquoise, grey, white and blue is/are claimed as a feature of the mark.
• GS0451: Licensing of industrial property; legal services
• GS0421: Scientific research within the medical, pharmaceutical and bacteriological area and providing scientific consultancy and information in relation to the aforementioned scientific research, conducting of tests regarding medical applications, namely, conducting clinical trials for others, packaging design, designing and development of medical equipment, designing pharmaceutical and medical preparations, preparation of pharmaceutical formulations, namely, pharmaceutical products development, design and development of granulation technology and tablet technology and providing scientific consultancy and information relating to the design and development of granulation technology and tablet technology

Case File Event Statements

• 2/12/2024 - 4 months ago

  37 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3

• 12/24/2021 - 2 years ago

  36 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 10/28/2021 - 2 years ago

  35 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 6/21/2019 - 5 years ago

  34 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 6/4/2019 - 5 years ago

  33 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 6/4/2019 - 5 years ago

  32 - FINAL DISPOSITION PROCESSED Type: FIMP

• 5/12/2019 - 5 years ago

  31 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 2/12/2019 - 5 years ago

  30 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 11/27/2018 - 5 years ago

  29 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 11/27/2018 - 5 years ago

  28 - PUBLISHED FOR OPPOSITION Type: PUBO

• 11/24/2018 - 5 years ago

  27 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 11/16/2018 - 5 years ago

  26 - REFUSAL PROCESSED BY IB Type: RFNT

• 11/7/2018 - 5 years ago

  25 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 11/7/2018 - 5 years ago

  24 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 11/7/2018 - 5 years ago

  23 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 10/17/2018 - 5 years ago

  22 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 9/28/2018 - 5 years ago

  21 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 9/27/2018 - 5 years ago

  20 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 9/27/2018 - 5 years ago

  19 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 9/17/2018 - 5 years ago

  18 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 9/17/2018 - 5 years ago

  17 - NON-FINAL ACTION E-MAILED Type: GNRT

• 9/17/2018 - 5 years ago

  16 - NON-FINAL ACTION WRITTEN Type: CNRT

• 8/17/2018 - 5 years ago

  15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 8/17/2018 - 5 years ago

  14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 8/16/2018 - 5 years ago

  13 - ASSIGNED TO LIE Type: ALIE

• 7/26/2018 - 5 years ago

  12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 7/24/2018 - 5 years ago

  11 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 7/24/2018 - 5 years ago

  10 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 2/16/2018 - 6 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 2/1/2018 - 6 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 2/1/2018 - 6 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 1/25/2018 - 6 years ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 1/24/2018 - 6 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 1/23/2018 - 6 years ago

  4 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 1/19/2018 - 6 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 1/19/2018 - 6 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 1/18/2018 - 6 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR